MedPath

A comparative clinical study on the management of urticaria by the oral use of adraka khanda with or without nimbadi lepa

Phase 3
Conditions
Health Condition 1: L502- Urticaria due to cold and heat
Registration Number
CTRI/2024/08/072289
Lead Sponsor
Institute of Post Graduate Ayurvedic Education and Research at SVSP Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients having signs and symptoms of Sheetapitta with the feature erythematous , oedematous papules and plaque wheals

Exclusion Criteria

Unconscious & semiconscious patients,malignancy - in any organ,systemic diseases like uncontrolled hypertension & diabetes mellitus,tuberculosis, paralysis and parkinsonism etc.Hyperlipidaema,

chronic renal failure,chronic liver disease,

pregnant women,long term steroid dependant.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The oral use of adraka khanda with local application of nimbadi lepa may show improvement in symptoms like erythmatous,oedematous papules and plaque wheals,itching,burning sensationTimepoint: 0th,14th Day,28th Day,42th Day
Secondary Outcome Measures
NameTimeMethod
The oral use of adraka khand with local application of nimbadi lepa may show improvement in objective parameter such as Ige,ESR,DC, TC testTimepoint: 0th,14th Day,28th day, 42th day
© Copyright 2025. All Rights Reserved by MedPath